Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
TFG Asset Management GP Ltd (CIK 1515070) reported $515.1M across 30 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: PATH ($279.8M, 54.32%), KGEI ($37.5M, 7.28%), WBD ($25.4M, 4.92%), WK ($14.9M, 2.89%), LYFT ($13.3M, 2.58%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PATH | UIPATH INC | $279.8M | 54.32% | 25.2M | Added |
| 2 | KGEI | KOLIBRI GLOBAL ENERGY INC | $37.5M | 7.28% | 6.8M | Trimmed |
| 3 | WBD | WARNER BROS DISCOVERY INC | $25.4M | 4.92% | 923,725 | New |
| 4 | WK | WORKIVA INC | $14.9M | 2.89% | 250,000 | Added |
| 5 | LYFT | LYFT INC | $13.3M | 2.58% | 1.0M | Hold |
| 6 | CXM | SPRINKLR INC | $13.2M | 2.56% | 2.2M | Hold |
| 7 | AUTL | AUTOLUS THERAPEUTICS LTD | $13.1M | 2.55% | 9.5M | Hold |
| 8 | CLDX | CELLDEX THERAPEUTICS INC NEW | $9.9M | 1.92% | 312,316 | Added |
| 9 | AXSM | AXSOME THERAPEUTICS INC. | $9.3M | 1.81% | 55,059 | Added |
| 10 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $8.0M | 1.55% | 127,198 | Added |
| 11 | NKTR | NEKTAR THERAPEUTICS | $7.4M | 1.44% | 103,037 | Added |
| 12 | ANNX | ANNEXON INC | $7.2M | 1.39% | 1.3M | Trimmed |
| 13 | PHVS | PHARVARIS N V | $6.3M | 1.22% | 221,611 | Added |
| 14 | ALKS | ALKERMES PLC | $5.7M | 1.10% | 159,791 | Added |
| 15 | AGIO | AGIOS PHARMACEUTICALS INC | $5.6M | 1.08% | 164,839 | Added |
| 16 | IMVT | IMMUNOVANT INC | $5.4M | 1.05% | 218,507 | Added |
| 17 | PRAX | PRAXIS PRECISION MEDICINES I | $5.1M | 1.00% | 15,952 | Trimmed |
| 18 | KRYS | KRYSTAL BIOTECH INC | $5.1M | 0.99% | 19,668 | Added |
| 19 | DYN | DYNE THERAPEUTICS INC | $4.7M | 0.91% | 258,132 | Added |
| 20 | AMLX | AMYLYX PHARMACEUTICALS INC | $4.4M | 0.86% | 317,877 | Added |
| 21 | MBX | MBX BIOSCIENCES INC | $4.3M | 0.84% | 145,480 | Added |
| 22 | DEFINIUM THERAPEUTICS INC | $3.8M | 0.73% | 199,994 | New | |
| 23 | SLNO | SOLENO THERAPEUTICS INC | $3.4M | 0.66% | 102,125 | New |
| 24 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $3.3M | 0.65% | 119,340 | Added |
| 25 | SLN | SILENCE THERAPEUTICS PLC | $3.3M | 0.64% | 630,161 | Added |
Source: SEC Form 13F filings · as of 2026-03-31